Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
The emerging role of MET/HGF inhibitors in oncology
HTML
Details
Locations
Year:
2013
Type:
review
Source:
Cancer Treatment Reviews
DOI:
10.1016/j.ctrv.2013.02.001
Authors:
Giorgio V. Scagliotti,
Silvia Novello,
Joachim von Pawel
Institutions:
Ospedale San Luigi Gonzaga,
University of Turin,
Asklepios Fachkliniken München-Gauting
Language:
English
Topic:
Cancer Mechanisms and Therapy
Subfield:
Cancer Research
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
MET receptor tyrosine kinase,
hepatocyte growth factor,
targeted cancer therapy,
tivantinib,
cabozantinib,
onartuzumab,
crizotinib,
rilotumumab,
non-small cell lung cancer,
hepatocellular carcinoma,
gastric cancer,
metastasis,
biomarkers,
patient selection
show all 14
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2055191970
FWCI:
2.932
Cites:
125
Cited by:
211
Related to:
10